Biotech Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis July 22, 2022
Biotech Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel July 22, 2022
Biotech Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 4, 2022 July 22, 2022
Biotech Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria July 22, 2022
Biotech BridgeBio Pharma Announces Academic Collaboration with Baylor College of Medicine to Advance Potential Therapies to Treat Genetic Diseases July 22, 2022
Biotech Bragar Eagel & Squire, P.C. Is Investigating Cassava, Hannon Armstrong, and Nio and Encourages Investors to Contact the Firm July 21, 2022
Biotech Myovant Sciences to Host First Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. Eastern Time on July 27, 2022 July 13, 2022
Search
Biotech
July 22, 2022
July 22, 2022
July 22, 2022
July 22, 2022
July 22, 2022
July 22, 2022
July 21, 2022
July 13, 2022
July 12, 2022
July 12, 2022
